Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Clinical & Developmental Immunology|March 9, 2012
Cytotoxic chemotherapy and CD4+ effector T cells: an emerging alliance for durable antitumor effectsZhi-Chun Ding, Gang ZhouCritical Reviews in Immunology|December 3, 2016
Immunostimulatory Effects of Melphalan and Usefulness in Adoptive Cell Therapy with Antitumor CD4+ T CellsMichal Kuczma, Zhi-Chun Ding, Gang ZhouOncoimmunology|January 23, 2015
Chemotherapy-induced myeloid suppressor cells and antitumor immunity: The Janus face of chemotherapy in immunomodulationZhi-Chun Ding, David H Munn, Gang ZhouThe FEBS Journal|June 22, 2010
Neuronal growth-inhibitory factor (metallothionein-3): structure-function relationshipsZhi-Chun Ding, Feng-Yun Ni, Zhong-Xian HuangJournal of Immunology (Baltimore, Md. : 1950)|January 19, 2011
Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell responseGang Zhou, Zhi-Chun Ding, Jie Fu, et al.Protein Expression and Purification|February 3, 2007
Overexpression and purification of single zinc finger peptides of human zinc finger protein ZNF191Dong-Xin Zhao, Zhi-Chun Ding, Yu-Qi Liu, et al.Frontiers in Immunology|February 11, 2021
The Monocytes That Repopulate in Mice After Cyclophosphamide Treatment Acquire a Neutrophil Precursor Gene Signature and Immunosuppressive ActivityZhi-Chun Ding, Nada S Aboelella, Locke Bryan, et al.Cancers|March 6, 2021
Oxidative Stress in the Tumor Microenvironment and Its Relevance to Cancer ImmunotherapyNada S Aboelella, Caitlin Brandle, Timothy Kim, et al.Blood|February 2, 2010
Chemotherapy rescues tumor-driven aberrant CD4+ T-cell differentiation and restores an activated polyfunctional helper phenotypeZhi-Chun Ding, Bruce R Blazar, Andrew L Mellor, et al.Blood|August 4, 2012
Polyfunctional CD4⁺ T cells are essential for eradicating advanced B-cell lymphoma after chemotherapyZhi-Chun Ding, Lei Huang, Bruce R Blazar, et al.Pageof 3